Third Arc Bio Competitors: 10 Similar Biotech

Third Arc Bio — investors and similar companies (62)

Companies comparable to Third Arc Bio in Biotech, headquartered in Boston, USA, ranked by how much of Third Arc Bio's verified investor base they share. 141 of the companies below have at least one backer in common with Third Arc Bio.

Overlap is computed from disclosed round records rather than from sector labels, so a company appears here because the same firms wrote cheques into both — the signal a founder benchmarking comparables or an investor mapping a sector actually wants. Each entry links to that company's own funding record and syndicate breakdown.

• Verified backers on record: 14
• Total disclosed funding: $165M
• Latest tracked round: Series A (2024-07-23)
• Sector: Biotech
• Headquarters: Boston, USA

• Vida Ventures
• Cormorant Asset Management
• Hillhouse Investment
• Omega Funds
• Goldman Sachs Alternatives
• BVF Partners LP
• T. Rowe Price Associates, Inc.
• Janus Henderson Investors
• abrdn Inc.
• Marshall Wace
• Foresite Capital
• Logos Capital
• Freepoint Capital Group
• AbbVie Ventures
• Pardes Biosciences — shares Foresite Capital
• Hexagon Bio — shares Vida Ventures
• Bluepha — shares Hillhouse Investment
• Cullinan Oncology — shares Vida Ventures
• Spyre Therapeutics — shares Cormorant Asset Management
• Kymera Therapeutics — shares Janus Henderson Investors
• Upstream Bio — shares Omega Funds
• ITeos Therapeutics — shares Janus Henderson Investors
• Bit Bio — shares Foresite Capital
• Cava Group
• Rigetti Computing
• Vividion Therapeutics
• Mammoth Biosciences — shares Foresite Capital
• BioNTech.de — shares Janus Henderson Investors
• OneAdvanced — shares Goldman Sachs Alternatives
• Alveus Therapeutics — shares Omega Funds
• Attralus — shares Logos Capital +2
• Aligos Therapeutics — shares Cormorant Asset Management +1
• Diagonal Therapeutics — shares Janus Henderson Investors
• Metagenomi — shares Marshall Wace
• Decibel Therapeutics — shares Foresite Capital
• ConsenSys — shares Marshall Wace
• Hydrostor — shares Goldman Sachs Alternatives
• Producers Midstream — shares Goldman Sachs Alternatives
• Kinnate Biopharma — shares Foresite Capital +3
• Minerva Neuroscience — shares Janus Henderson Investors +2
• Verve Therapeutics — shares Cormorant Asset Management +2
• Genapsys Inc. — shares Foresite Capital
• Epirus
• Aspen Neuroscience — shares Cormorant Asset Management
• Verdiva Bio — shares Logos Capital
• Gracell Biotechnologies — shares Janus Henderson Investors +1
• Ripple — shares Marshall Wace
• TRex Bio — shares Janus Henderson Investors
• Soufflé Therapeutics — shares Vida Ventures
• VelosBio — shares Cormorant Asset Management +3
• Lycia Therapeutics — shares Janus Henderson Investors +1
• Triveni Bio — shares Janus Henderson Investors +2
• Ollin Biosciences — shares Foresite Capital
• Delfi Diagnostics — shares Foresite Capital
• AIDOC — shares Goldman Sachs Alternatives
• Mirador Therapeutics — shares Logos Capital
• Morphic Therapeutic — shares Omega Funds
• PACT Pharma — shares Vida Ventures
• Aviceda Therapeutics — shares Omega Funds
• Ray Therapeutics — shares Janus Henderson Investors +1
• D-Robotics — shares Hillhouse Investment
• Catalym — shares Omega Funds

Third Arc Bio funding profile · All research reports